162 related articles for article (PubMed ID: 23595961)
21. Angiopoietin-like proteins and postprandial partitioning of fatty acids.
DiDonna NM; Chen YQ; Konrad RJ
Curr Opin Lipidol; 2022 Feb; 33(1):39-46. PubMed ID: 34789669
[TBL] [Abstract][Full Text] [Related]
22. Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL.
Westerterp M; de Haan W; Berbée JF; Havekes LM; Rensen PC
J Lipid Res; 2006 Jun; 47(6):1203-11. PubMed ID: 16537968
[TBL] [Abstract][Full Text] [Related]
23. Atypical angiopoietin-like protein that regulates ANGPTL3.
Quagliarini F; Wang Y; Kozlitina J; Grishin NV; Hyde R; Boerwinkle E; Valenzuela DM; Murphy AJ; Cohen JC; Hobbs HH
Proc Natl Acad Sci U S A; 2012 Nov; 109(48):19751-6. PubMed ID: 23150577
[TBL] [Abstract][Full Text] [Related]
24. Inducible ApoE gene repair in hypomorphic ApoE mice deficient in the low-density lipoprotein receptor promotes atheroma stabilization with a human-like lipoprotein profile.
Eberlé D; Luk FS; Kim RY; Olivas VR; Kumar N; Posada JM; Li K; Gaudreault N; Rapp JH; Raffai RL
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1759-67. PubMed ID: 23788760
[TBL] [Abstract][Full Text] [Related]
25. Hepatic ANGPTL3 regulates adipose tissue energy homeostasis.
Wang Y; McNutt MC; Banfi S; Levin MG; Holland WL; Gusarova V; Gromada J; Cohen JC; Hobbs HH
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11630-5. PubMed ID: 26305978
[TBL] [Abstract][Full Text] [Related]
26. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
27. Resistance of chylomicron and VLDL remnants to post-heparin lipolysis in ApoE-deficient mice: the role of apoE in lipoprotein lipase-mediated lipolysis in vivo and in vitro.
Zsigmond E; Fuke Y; Li L; Kobayashi K; Chan L
J Lipid Res; 1998 Sep; 39(9):1852-61. PubMed ID: 9741698
[TBL] [Abstract][Full Text] [Related]
28. Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activity.
Chen YQ; Yang Y; Zhen EY; Beyer TP; Li H; Wen Y; Ehsani M; Jackson N; Xie K; Jung H; Scheithauer JL; Kumari A; Birrane G; Russell AM; Balasubramaniam D; Liao Z; Siegel RW; Qian Y; Ploug M; Young SG; Konrad RJ
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2322332121. PubMed ID: 38625948
[TBL] [Abstract][Full Text] [Related]
29. Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4.
Landfors F; Chorell E; Kersten S
J Lipid Res; 2023 Jan; 64(1):100313. PubMed ID: 36372100
[TBL] [Abstract][Full Text] [Related]
30. [Protection of huanglian jiedu decoction on livers of hyperlipidemia mice].
Ma YL; Li T; Wang BB; Jia B; Chen B; Su J; Wang XB; Zeng H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Aug; 33(8):1107-11. PubMed ID: 24325064
[TBL] [Abstract][Full Text] [Related]
31. Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice.
Niho N; Mutoh M; Takahashi M; Tsutsumi K; Sugimura T; Wakabayashi K
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2970-4. PubMed ID: 15710887
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
Kypreos KE; Li X; van Dijk KW; Havekes LM; Zannis VI
Biochemistry; 2003 Aug; 42(33):9841-53. PubMed ID: 12924933
[TBL] [Abstract][Full Text] [Related]
33. Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.
Medh JD; Fry GL; Bowen SL; Ruben S; Wong H; Chappell DA
J Lipid Res; 2000 Nov; 41(11):1858-71. PubMed ID: 11060356
[TBL] [Abstract][Full Text] [Related]
34. In Silico Description of the Direct Inhibition Mechanism of Endothelial Lipase by ANGPTL3.
Montavoci L; Ben Mariem O; Saporiti S; Laurenzi T; Palazzolo L; Ossoli AF; Guerrini U; Calabresi L; Eberini I
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542527
[TBL] [Abstract][Full Text] [Related]
35. ANGPTL3 (Angiopoietin-Like 3) Preferentially Resides on High-Density Lipoprotein in the Human Circulation, Affecting Its Activity.
Kraaijenhof JM; Tromp TR; Nurmohamed NS; Reeskamp LF; Langenkamp M; Levels JHM; Boekholdt SM; Wareham NJ; Hoekstra M; Stroes ESG; Hovingh GK; Grefhorst A
J Am Heart Assoc; 2023 Nov; 12(21):e030476. PubMed ID: 37889183
[TBL] [Abstract][Full Text] [Related]
36. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms.
Shan L; Yu XC; Liu Z; Hu Y; Sturgis LT; Miranda ML; Liu Q
J Biol Chem; 2009 Jan; 284(3):1419-24. PubMed ID: 19028676
[TBL] [Abstract][Full Text] [Related]
37. A highly conserved motif within the NH2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization.
Yau MH; Wang Y; Lam KS; Zhang J; Wu D; Xu A
J Biol Chem; 2009 May; 284(18):11942-52. PubMed ID: 19246456
[TBL] [Abstract][Full Text] [Related]
38. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase.
Shimizugawa T; Ono M; Shimamura M; Yoshida K; Ando Y; Koishi R; Ueda K; Inaba T; Minekura H; Kohama T; Furukawa H
J Biol Chem; 2002 Sep; 277(37):33742-8. PubMed ID: 12097324
[TBL] [Abstract][Full Text] [Related]
39. Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice.
Sberna AL; Assem M; Xiao R; Ayers S; Gautier T; Guiu B; Deckert V; Chevriaux A; Grober J; Le Guern N; Pais de Barros JP; Moore DD; Lagrost L; Masson D
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2232-9. PubMed ID: 21778422
[TBL] [Abstract][Full Text] [Related]
40. Identification of a small molecule that stabilizes lipoprotein lipase in vitro and lowers triglycerides in vivo.
Larsson M; Caraballo R; Ericsson M; Lookene A; Enquist PA; Elofsson M; Nilsson SK; Olivecrona G
Biochem Biophys Res Commun; 2014 Jul; 450(2):1063-9. PubMed ID: 24984153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
